Back to company

SPECIALLÆGE I ALMEN MEDICIN AGATA BRYLSKA ApS: Financial statements 2023

CVR: 33055846

SPECIALLÆGE I ALMEN MEDICIN AGATA BRYLSKA ApS (CVR 33055846) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 2,358,708 and a net result of DKK 409,877 compared with DKK 349,589 the year before. That is an increase of 7.2% compared with the year before. Equity amounted to DKK 490,077. The solvency ratio was 53.2%. The company had 4 employees in the financial year.

Gross Profit
2,358,708 kr.
Profit/Loss
409,877 kr.
Equity
490,077 kr.
Total Assets
920,787 kr.
Employees
4

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-2.4 mio.410 t.490 t.4
2022-2.2 mio.350 t.430 t.3
2021-2.3 mio.610 t.690 t.3
2020-2.1 mio.424 t.516 t.3
2019-2.2 mio.511 t.592 t.3

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

About SPECIALLÆGE I ALMEN MEDICIN AGATA BRYLSKA ApS

SPECIALLÆGE I ALMEN MEDICIN AGATA BRYLSKA ApS is a Danish company of the type Anpartsselskab based in Aabenraa, founded in 2010. The company is registered under the industry Speciallægers aktiviteter. The management consists of Agata Brylska. The company is owned by Agata Brylska. The company has 4 employees. In 2025, the company reported a gross profit of DKK 2,333,145 and a net result of DKK 380,001 compared with DKK 448,486 the year before. Equity amounted to DKK 460,000.